News & Updates

Inhaled budesonide may be effective for treating early COVID-19 in adults

21 Sep 2021 by

The administration of inhaled budesonide for the treatment of early COVID-19 in adults reduced the probability of needing urgent medical care and time to recovery, according to findings from the STOIC* trial presented at ERS 2021.

Inhaled budesonide may be effective for treating early COVID-19 in adults

21 Sep 2021

Pitolisant may manage residual sleepiness in OSA patients on CPAP

20 Sep 2021 by

The histamine H3-receptor antagonist/inverse agonist pitolisant showed a favourable risk-benefit profile in managing residual excessive daytime sleepiness (EDS) in individuals receiving continuous positive airway pressure (CPAP) for obstructive sleep apnoea (OSA), according to data from the HAROSA 1 trial presented at ERS 2021.

Pitolisant may manage residual sleepiness in OSA patients on CPAP

20 Sep 2021

Original New Drug Application Approvals by US FDA (01-15 September 2021)

20 Sep 2021

New drug applications approved by US FDA as of 01-15 September 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 September 2021)

20 Sep 2021

Flu vaccine cuts all-cause, CV death risk in cardiac patients

17 Sep 2021 by

Receiving an influenza vaccination after hospitalization for an invasive coronary procedure or a myocardial infarction (MI) may reduce the risk of all-cause or cardiovascular (CV) death, according to results of the IAMI* trial.

Flu vaccine cuts all-cause, CV death risk in cardiac patients

17 Sep 2021

Moderna vs Pfizer vax: Is one better against Delta?

16 Sep 2021 by

While both mRNA vaccines available on the market are strongly protective against SARS-CoV-2 infection and severe COVID-19 illness, emerging real-world data suggest that Moderna’s mRNA-1273 is more effective than Pfizer-BioNTech’s BNT162b2 vaccine in the face of Delta predominance.

Moderna vs Pfizer vax: Is one better against Delta?

16 Sep 2021

Air pollution strongly correlated with atherogenesis; intervention study planned

15 Sep 2021 by

A study by the Chinese University of Hong Kong (CUHK) and Chongqing Medical University finds a strong association between air pollution and markers of early atherosclerosis, suggesting a potential target for preventive intervention.

Air pollution strongly correlated with atherogenesis; intervention study planned

15 Sep 2021

PRISm common among Japan’s elderly, impacts physical function

10 Sep 2021

Preserved ratio impaired spirometry (PRISm) is highly common among Japan’s elderly adults, exceeding the prevalence of obstructive lung disease, and could lead to reduced respiratory and physical function, a recent study has found.

PRISm common among Japan’s elderly, impacts physical function

10 Sep 2021

Delta doubles risk of severe COVID-19 among the unvaccinated

09 Sep 2021 by

The risk of hospitalization is more than doubled in patients infected with the Delta variant vs the Alpha variant, in particular among people who were unvaccinated, reveals a large cohort study — sounding the alarm that Delta is not only more transmissible, but also more virulent.

Delta doubles risk of severe COVID-19 among the unvaccinated

09 Sep 2021

Hospital-acquired COVID-19 driven by patients, rather than HCWs

06 Sep 2021 by

Hospital-acquired COVID-19 is more likely to be spread from other infected patients, rather than from healthcare workers, a study has shown.

Hospital-acquired COVID-19 driven by patients, rather than HCWs

06 Sep 2021

Two doses of COVID-19 vaccine crucial to maximize effectiveness against delta variant

03 Sep 2021 by

Although both the BNT162b2 and ChAdOx1 nCoV-19 vaccines appear to be effective against symptomatic disease caused by the delta variant of the SARS-CoV-2 virus, the effectiveness is lower than that against the alpha variant. However, this reduced effectiveness was less pronounced after two doses of the vaccine, a recent study from England showed.

Two doses of COVID-19 vaccine crucial to maximize effectiveness against delta variant

03 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

Inhaled budesonide may be effective for treating early COVID-19 in adults

Inhaled budesonide may be effective for treating early COVID-19 in adults

Pitolisant may manage residual sleepiness in OSA patients on CPAP

Pitolisant may manage residual sleepiness in OSA patients on CPAP

Original New Drug Application Approvals by US FDA (01-15 September 2021)

Original New Drug Application Approvals by US FDA (01-15 September 2021)

Flu vaccine cuts all-cause, CV death risk in cardiac patients

Flu vaccine cuts all-cause, CV death risk in cardiac patients

Moderna vs Pfizer vax: Is one better against Delta?

Moderna vs Pfizer vax: Is one better against Delta?

Air pollution strongly correlated with atherogenesis; intervention study planned

Air pollution strongly correlated with atherogenesis; intervention study planned

PRISm common among Japan’s elderly, impacts physical function

PRISm common among Japan’s elderly, impacts physical function

Delta doubles risk of severe COVID-19 among the unvaccinated

Delta doubles risk of severe COVID-19 among the unvaccinated

Hospital-acquired COVID-19 driven by patients, rather than HCWs

Hospital-acquired COVID-19 driven by patients, rather than HCWs

Two doses of COVID-19 vaccine crucial to maximize effectiveness against delta variant

Two doses of COVID-19 vaccine crucial to maximize effectiveness against delta variant